Skip to main content

Table 2 classes of antibiotic prescribed among hospitalized patients based on the indications

From: Antibiotic use among hospitalized patients in northern Nigeria: a multicenter point-prevalence survey

Classes of antibiotic

Frequency (%)

Total

CI

HI

SP

MP

UI

Nitroimidazoles

128 (28.5)

46 (26.4)

23 (31.5)

34 (33.7)

13 (19.4)

12 (35.3)

Third generation cephalosporins

85 (18.9)

26 (14.9)

15 (20.5)

21 (20.8)

16 (23.9)

7 (20.6)

Fluoroquinolones

61 (13.6)

33 (19.0)

8 (11.0)

8 (7.9)

5 (7.5)

7 (20.6)

Penicillins – beta lactamase inhibitors

47 (10.5)

18 (10.3)

8 (11.0)

11 (10.9)

7 (10.4)

3 (8.8)

Aminoglycosides

38 (8.5)

13 (7.5)

10 (13.7)

4 (4.0)

10 (14.9)

1 (2.9)

Penicillins

38 (8.5)

11 (6.3)

4 (5.5)

8 (7.9)

12 (17.9)

3 (8.8)

Second generation cephalosporins

17 (3.8)

6 (3.4)

2 (2.7)

9 (8.9)

0 (0.0)

0 (0.0)

Lincosamides

14 (3.1)

9 (5.2)

1 (1.4)

3 (3.0)

1 (1.5)

0 (0.0)

Macrolides

8 (1.8)

6 (3.4)

0 (0.0)

1 (1.0)

1 (1.5)

0 (0.0)

Sulphonamides

4 (0.9)

2 (1.1)

1 (1.4)

0 (0.0)

1 (1.5)

0 (0.0)

Tetracyclines

4 (0.9)

1 (0.6)

0 (0.0)

2 (2.0)

0 (0.0)

1 (2.9)

Amphenicols

3 (0.7)

3 (1.7)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

Carbapenems

1 (0.2)

0 (0.0)

1 (1.4)

0 (0.0)

0 (0.0)

0 (0.0)

Nitrofuran derivatives

1 (0.2)

0 (0.0)

0 (0.0)

0 (0.0)

1 (1.5)

0 (0.0)

Proportion of broad spectrum antibiotics

147 (32.7)

59 (33.9)

32 (43.8)

42 (41.6)

21 (31.3)

14 (41.2)

  1. CI Community acquired infections, HI Hospital acquired infections, SP Surgical prophylaxis, MP Medical prophylaxis and UI Unknown indication